HTRA1 and age-related macular degeneration: The two homozygous low‐risk donors were selected on the basis of low‐risk for all three single nucleotide polymorphisms (SNPs) rs11200638 (HTRA1), rs1061170 (CFH), and rs10490924 (ARMS2) and no clinical manifestation of AMD.